Andreas Gruentzig Center
A Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy of Tirofiban Using a High-Dose Bolus Plus a Shortened Infusion Duration Versus Label-Dosing Eptifibatide in Patients Undergoing Percutaneous Coronary Intervention
Purpose: The purpose this study is to assess whether a tirofiban regimen of a high-dose bolus plus a shortened infusion duration compared to label-dosing eptifibatide in patients undergoing percutaneous coronary intervention (PCI) is associated with a non-inferior composite rate of death, PCI-related myocardial infarction, urgent target vessel revascularization or in-hospital major bleeding within 48 hours following PCI or hospital discharge, whichever comes first.
- Age >18 years of age
- Scheduled to undergo PCI with an approved device in one or more target lesions
- Written informed consent
Sponsor: St. Jude Medical
Purpose: To define and evaluate OCT stent guidance parameters through prospective data collection in PCI procedures of de novo lesions.
This study is no longer open to enrollment.